Jody Lemarr-cabano, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 202 W 5th Ave, Corsicana, TX 75110 Phone: 903-872-5681 Fax: 903-872-0603 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 400 N 15th St, Corsicana, TX 75110 Phone: 903-229-4141 |
Corsicana First Eyecare Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 400 N 15th St, Corsicana, TX 75110 Phone: 903-872-2561 Fax: 903-872-5273 |
Meridith Musgrove, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 800 N Beaton St, Corsicana, TX 75110 Phone: 903-874-0005 Fax: 903-874-0009 |
Byron E. Advent, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 105 W. 7th Ave, Suite 800, Corsicana, TX 75110 Phone: 903-874-0005 Fax: 903-874-0009 |
Max J Worley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 202 W 5th Ave, Corsicana, TX 75110 Phone: 903-872-5681 Fax: 903-872-0603 |
Corsicana Envision Eyecare Pa Optometrist Medicare: Medicare Enrolled Practice Location: 202 W 5th Ave, Corsicana, TX 75110 Phone: 903-872-5681 Fax: 903-872-0603 |
Daniel Luke Ewing, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 800 N Beaton St, Corsicana, TX 75110 Phone: 903-874-0005 Fax: 903-874-0009 |
Dr. Matthew David Parker, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 400 N 15th St, Corsicana, TX 75110 Phone: 903-229-4141 Fax: 903-872-5273 |
Dr. Ronald Lewis Redder, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 400 N 15th St, Corsicana, TX 75110 Phone: 903-229-4141 Fax: 903-872-5273 |
First Eye Care Corsicanna Optometrist Medicare: Not Enrolled in Medicare Practice Location: 400 N 15th St, Corsicana, TX 75110 Phone: 903-872-2561 Fax: 903-872-5273 |
News Archive
Many scientists dream of making a single discovery that provides fundamental insight into nature, may be used to help save human lives, and can assist in the preservation of an endangered species. In new research reported in the journal Cell, a Japanese team is on the verge of accomplishing this nearly impossible feat.
Cyclacel Pharmaceuticals, Inc. announced today 1-year survival data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in older patients with myelodysplastic syndromes refractory to hypomethylating agents, such as azacitidine and decitabine. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
The PBS NewsHour blog "The Rundown" features excerpts from interviews with three experts discussing the recent debate over research conducted on the H5N1 bird flu virus.
Takeda Global Research & Development Center, Inc. U.S., today announced results from three phase 3 studies of the investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone.
› Verified 9 days ago